Navigation Links
Boston Medical Center cardiologist receives Drake Award
Date:2/10/2009

(Boston) Newton resident Alice Jacobs, MD, FACC, FAHA, director of the Cardiac Catheterization Laboratory and Interventional Cardiology at Boston Medical Center is the recipient of the Drake Award. The award was presented at the Annual Maine Scientific Session's 59th annual conference in Bethel, Maine.

The Drake Award is presented every year in memory of Dr. Eugene Drake, considered to be the first physician in Maine to specialize in the treatment of heart disease. He was also co-founder of the American Heart Association, Maine Affiliate and dedicated his career to carrying out the American Heart Association mission. This award is given to physicians who have made significant contributions in cardiovascular disease research, treatment and education.

The conference was geared toward improving the knowledge and awareness of cardiovascular and stroke issues in acute-care areas to health-care professionals in the hopes of improving patient outcomes. In addition to being presented with the award during the weekend conference, Jacobs also gave a presentation on the current concepts and controversies surrounding myocardial infarction. Jacobs gave an update on the current status of reperfusion therapy for a STEMI (ST-elevation myocardial infarction) heart attack, as well as discussing the barriers to widespread implementation of systems of care for STEMI patients.

Jacobs is a professor of medicine at Boston University School of Medicine and past president of the American Heart Association (AHA). She was also a member of several American College of Cardiology (ACC) writing groups establishing training criteria in interventional cardiology, assessing and maintaining competence in interventional cardiology, and updating the ACC/AHA guidelines for the performance of percutaneous coronary intervention.

She serves as chair of the ACC/AHA Task Force on Practice Guidelines, vice president of the Association of University Cardiologists, and is a member of the American Board of Internal Medicine Interventional Cardiology Self-Assessment Test Committee and the New York State Cardiac Advisory Committee.

Jacobs major research interest is in coronary revascularization strategies. She is also interested in cardiovascular disease in women and the gender differences in the epidemiology, diagnosis, treatment and prognosis of ischemic heart disease. Currently, she is leading the AHA's Mission: Lifeline, a community-based, national initiative to develop strategies to increase the number of ST-elevation myocardial infarction patients with timely access to primary PCI. She is the principal investigator of the MASS COMM trial evaluating the safety and efficacy of coronary angioplasty performed in community hospitals without on-site cardiac surgery in Massachusetts.


'/>"/>

Contact: Michelle Roberts
michelle.roberts@bmc.org
617-638-8491
Boston University
Source:Eurekalert

Related medicine news :

1. Next Generation Ad Agency Gray & Partners Opens Headquarters in Boston
2. BioInformatics, LLC, A Recognized Sponsor of First Annual Consumer Genetics Show in Boston, June 9-11, 2009
3. Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2008
4. Boston Scientific and Medtronic Reach Agreement on Patent Disputes
5. Its Cold Outside! Warm Up in Select Downtown Boston Heated Bus Shelters Courtesy of TYLENOL(r) Warming Liquids
6. Boston Scientific Awarded CRM Contract by Department of Veterans Affairs
7. BioMed Realty Trusts Center for Life Science Boston Now 91% Leased
8. Boston Scientific Announces Court Decision
9. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2008 Financial Results
10. Boston Scientific to Participate in JP Morgan Health Care Conference
11. Boston Hyundai Dealer Teams up With the Red Cross to Save Lives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 2016 , ... The Valentine’s Season is famous for gift giving with flowers, chocolates and other ... loved. This year, for more than 5.6 million Americans suffering with Alzheimer’s, those store ... to remind them of the lives they’ve led and the people they’ve touched. ...
(Date:2/8/2016)... ... 08, 2016 , ... Tingley Rubber Corporation , a ... its range of unique and advantaged protective solutions to a growing and ... bilingual customer service and marketing support. A new distribution center in Brampton, Ontario ...
(Date:2/8/2016)... ... February 08, 2016 , ... Delta Dental of California ... combat pancreatic cancer. , Gary D. Radine, who recently retired as president and CEO ... Cancer Society’s 2015 CEO of the Year , helped lead the effort to ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... wide variety of organizations. DocuSyst provides a cloud hosted environment for FileHold ... installations include integration with various 3rd party applications using the FileHold web services ...
(Date:2/8/2016)... , ... February 08, 2016 , ... TopConsumerReviews.com recently awarded ... Mole removal products. , Moles are derived from a cluster of melanin when exposed ... the wrong places and create a lifetime of embarrassment. Historically, mole removal ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... CITY, Calif., Feb. 8, 2016  Aoxing Pharmaceutical Company, Inc. (NYSE ... fiscal year 2016, ended December 31, 2015, the Company achieved ... recorded in the same quarter in fiscal 2015. ... in Q2 of fiscal year 2016 was $2,068,635, or $.03 ... or $.01 per share, in the Q2 of fiscal year ...
(Date:2/8/2016)... Feb. 8, 2016 ... of the "Label-Free Detection Market by ... 2020" report to their offering. ... addition of the "Label-Free Detection Market ... to 2020" report to their offering. ...
(Date:2/8/2016)...  HemaFlo Therapeutics, Inc. announced today that the United States ... 9,119,880 covering the use of NephroFlow to treat acute kidney ... founder, said, "We are pleased to secure our rights to ... , PhD, HemaFlo,s founder, said, "We are pleased to secure ... Dale Peterson , PhD, HemaFlo,s founder, said, "We ...
Breaking Medicine Technology: